InvestorsHub Logo
Followers 276
Posts 32701
Boards Moderated 0
Alias Born 11/14/2013

Re: None

Monday, 12/23/2013 11:34:49 AM

Monday, December 23, 2013 11:34:49 AM

Post# of 700557
This is the only thing I can find from NWBO regarding the ongoing results for DCVAX-L in Israel.

Approximately July 17, 2013.

Regarding Compassionate Use Program.

"Although we do not have reportable data on the success of administering DCVax-L for patients with recurrent GBM, we have some anecdotal evidence of good results." -- NWBO Patient Liason

http://www.cancercompass.com/message-board/message/all,72718,0.htm

If it were reportable data, it would undermine the FDA and EMA trials. So I think this is the furthest NWBO can go in sharing compassionate use success. However, an investigative journalist might be able to get further with the medical staff in Israel, or former patients, if they were so inclined.

When speaking to the former patients in the compassionate use program, they might be willing to share what the medical staff thought about DCVAX.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News